One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Biosimilars and the era of interchangeability
doi : 10.1016/S2665-9913(23)00213-8
Volume 5, Issue 9, September 2023, Page e495
The global burden of osteoarthritis: past and future perspectives
doi : 10.1016/S2665-9913(23)00207-2
Volume 5, Issue 9, September 2023, Pages e496-e497
Calcium pyrophosphate deposition disease moves into the spotlight
Nicola Dalbeth a, Sara K Tedeschi b
Multiple switching studies and interchangeability of biosimilars
Jonathan Kay a b c
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
doi : 10.1016/S2665-9913(23)00215-1
Volume 5, Issue 9, September 2023, Pages e501-e506
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
doi : 10.1016/S2665-9913(23)00163-7
Volume 5, Issue 9, September 2023, Pages e508-e522
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial
Prof Tristan Pascart MD PhD a, Pierre Robinet MD b, Sébastien Ottaviani MD g, Rémi Leroy MD h, Nicolas Segaud MD i, Aurore Pacaud MD a, Agathe Grandjean MD a, Hélène Luraschi MD j, Thibault Rabin MD a, Xavier Deplanque MD k, Pierre Maciejasz MD k, Fabien Visade MD PhD b, Alexandre Mackowiak MD c, Nicolas Baclet MD PhD l, Prof Sylvestre Maréchaux MD PhD d, Antoine Lefebvre PharmD e, Prof Jean-François Budzik MD PhD f, Prof Thomas Bardin MD PhD m, Prof Pascal Richette MD PhD m, Laurène Norberciak BSc n…Prof Eric Houvenagel MD a
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study
Prof Roy M Fleischmann MD a, Wassim Saikali MD c, Prof Sharad Lakhanpal MD b, Daniel F Alvarez MD d, Donna S Cox PhD d, Claudia Ana Ianos MD e, Wuyan Zhang PhD f, Carol Cronenberger PhD d, Karen Wang BS g
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
Prof Kim Papp MD a b, Richard B Warren MD c, Prof Lawrence Green MD d, Prof Kristian Reich MD e, Prof Richard G Langley MD f, Prof Carle Paul MD g, Prof Akihiko Asahina MD h, Lynne Johnson MSN i, Vipin Arora PhD i, Olawale Osuntokun MD i, Prof Mark Lebwohl MD j
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
Peter A Johnson DPhil a, Jessica E Ackerman PhD a, Prof Mariola Kurowska-Stolarska PhD b, Prof Mark Coles PhD a, Prof Christopher D Buckley PhD a, Prof Stephanie G Dakin PhD a
ROSAH syndrome: childhood-onset arthritis, hand deformities, uveitis, and splenomegaly
doi : 10.1016/S2665-9913(22)00360-5
Volume 5, Issue 9, September 2023, Page e564
